Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
KALY
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
finance.yahoo.comPOSITIVO
PAOG CBD RELAX-RX Co-Packing with ALKM And Marketing with USMJ Detailed In Update Scheduled Next Week
Sandusky, Ohio--(Newsfile Corp. - March 9, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today announced an update scheduled one week from today, for Tuesday, March 16, 2021 to publish details on the company's CBD RELAX-RX nutraceutical develop…
PAOG CBD RELAX-RX Co-Packing with ALKM And Marketing with USMJ Detailed In Update Scheduled Next Week
Sandusky, Ohio--(Newsfile Corp. - March 9, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today announced an update scheduled one week from today, for Tuesday, March 16, 2021 to publish details on the company's CBD RELAX-RX nutraceutical develop…
PAOG Targets $18 Billion Anxiety And Depression Treatment Market
Sandusky, Ohio--(Newsfile Corp. - February 11, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today announced the company's recently announced CBD nutraceutical development expansion will target the anxiety and depression treatment market antici…
PAOG Plans To Add CBD Nutraceutical Revenue In 2021 To Cannabis Cultivation Revenue
Sandusky, Ohio--(Newsfile Corp. - February 10, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today announced the company plans to add revenue this year in 2021 from its developing CBD nutraceutical business to currently anticipated revenue from…
PAOG Plans To Add CBD Nutraceutical Revenue In 2021 To Cannabis Cultivation Revenue
Sandusky, Ohio--(Newsfile Corp. - February 10, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today announced the company plans to add revenue this year in 2021 from its developing CBD nutraceutical business to currently anticipated revenue from…
PAOG Confirms CBD Pharmaceutical And Nutraceutical Product Development Presentation Schedule
SANDUSKY, Ohio, Feb. 9, 2021 /PRNewswire/ -- PAO Group, Inc. (USOTC: PAOG) today confirmed plans to publish a multimedia presentation next week on the company's strategy to expand its nutraceutical product reach. The company added today th…
PAOG Confirms CBD Pharmaceutical And Nutraceutical Product Development Presentation Schedule
SANDUSKY, Ohio, Feb. 9, 2021 /PRNewswire/ -- PAO Group, Inc. (USOTC: PAOG) today confirmed plans to publish a multimedia presentation next week on the company's strategy to expand its nutraceutical product reach. The company added today th…
KALY – Kali-Extracts Anticipates Reaching $1 Million In 2019 Revenue With Q4 Hemp Extraction Contribution
DALLAS, Nov. 29, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced that it anticipates reaching $1 million in revenue by year end 2019 with the contr…
KALY – Kali-Extracts Could Reach $1 Million In Total 2019 Revenue
DALLAS, Nov. 27, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today confirmed that it has the potential to reach $1 million in revenue by year end 2019. The com…
KALY – Kali-Extracts Confirms Cannabis Biopharmaceutical Capital Infusion Plans
DALLAS, Nov. 21, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today confirmed introducing a third option to compete with the two acquisition offers currently be…
KALY – Kali-Extracts Introduces Third Option To Compete With Two $50 Million Acquisition Offers
DALLAS, Nov. 20, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced introducing a third option to compete with the two acquisition offers currently be…
KALY – Kali-Extracts Confirms Second Bid On Its Cannabis Biopharmaceutical Technology Valued At $50 Million
DALLAS, Nov. 12, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today confirmed a second party has approached the company to express interest in acquiring KALY’s…
KALY – Kali-Extracts Announces Second Bidder On Its Cannabis Biopharmaceutical Technology Valued At $50 Million
DALLAS, Nov. 08, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced a second party has approached the company to express interest in acquiring KALY’s…
KALY – Kali-Extracts Encounters Second Wave Of CBD Extraction Contract Opportunities
DALLAS, Nov. 06, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced that the company’s CBD extraction offering is beginning to see a second wave of co…
KALY – Kali-Extracts Explores $50 Million Cannabis Biopharmaceutical Technology Sale
DALLAS, Oct. 31, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced taking a next step with the investor that has recently valued KALY’s biopharmaceut…
KALY - Kali-Extracts Announces Third CBD Extraction Agreement Adding To $15 Million In Current Contracts
DALLAS, Oct. 30, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced a new CBD extraction agreement adding to the company’s previously announced extrac…
KALY – Kali Extracts Announces USDA Organic Certification For First Hemp Crop
DALLAS, Oct. 30, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced a USDA Organic Certification for its first crop hemp crop. KALY has a U.S. Patent…
DALLAS, Oct. 30, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced a $50 Million valuation for its cannabis extract biopharmaceutical technology. The…
KALY – Kali-Extracts To Review Acquisition Interest In Its Cannabis Extract Biopharmaceutical Technology This Wednesday, October 30, 2019
DALLAS, Oct. 28, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced plans to issue an update this Wednesday, October 30th, 2019 regarding the recent a…
KALY – Kali Extracts CEO Explores Hemp Expansion Industry In North Carolina
DALLAS, Oct. 25, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced CEO Frederick Ferri met with Butterball’s Jim Maxwell and North Carolina 7th Distr…
KALY – Kali-Extracts Confirms Acquisition Interest In Its Cannabis Extract Biopharmaceutical Technology
DALLAS, Oct. 24, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today confirmed a recent conditional acquisition proposal from an investor interested in the acqui…
KALY – Kali-Extracts Announces New CBD Hemp4mula Gummies Now Available On USMJ.com
DALLAS, Oct. 23, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced its new CBD Hemp4mula Gummies are now available to order on www.usmj.com. www.usmj…
KALY – Kali-Extracts Announces Getting Courted For Potential Sale Of Cannabis Extract Biopharmaceutical Technology
DALLAS, Oct. 23, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced the company has recently received serious interest from an investor exploring the…
KALY – Kali-Extracts Publishes Photos From Historic First Legal Hemp Harvest
DALLAS, Oct. 17, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today published photos on the company’s website from its first historic hemp harvest since the Fed…
KALY – Kali-Extracts Reports Increased Interest In Patented Cannabis Extraction Process In Reaction To Cannabis 2.0
DALLAS, Oct. 15, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced recent interest from Canadian cannabis sector businesses in reaction to Cannabis 2…
KALY – Kali-Extracts Hemp Harvest And CBD Extraction In Full Swing
DALLAS, Oct. 14, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced engaging a photo journalist to record the company’s first historic hemp harvest si…
DALLAS, Oct. 11, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced today announced that as part of the sole license it has granted to Puration, Inc.…
KALY – Kali-Extracts Announces Exploding Demand For Its CBD Extraction Services
DALLAS, Oct. 10, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced what it referred to as “exploding” demand for its CBD extraction services. KALY ha…
KALY – Kali-Extracts Developing OTC and Prescription CBD Treatments
DALLAS, Oct. 08, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today confirmed the company is pursuing the development of Over-The-Counter (OTC) and prescription…
DALLAS, Oct. 04, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced an anticipated jump in revenue in Q4 2019 related to the company’s CBD extraction…
KALY – Kali-Extracts Confirms CBD Extract Biopharmaceutical Business Update Scheduled Monday October 7, 2019
DALLAS, Oct. 03, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today confirmed the company has schedule a presentation for next week on Monday, October 7, 2019 t…
KALY – Kali-Extracts Consumer Cannabis Extract Business Reports Growing Revenue Bolstering Its Long Term Biopharmaceutical Strategy
DALLAS, Oct. 01, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today highlighted the progress of Puration, Inc. (USOTC: PURA) reporting today a new European dist…